Balixafortide TFA (POL6326 TFA) is a potent, selective, well-tolerated peptidic CXCR4 antagonist with an IC50 < 10 nM. Balixafortide TFA shows 1000-fold selective for CXCR4 than a large panel of receptors including CXCR7. Balixafortide TFA blocks beta-arrestin recruitment and calcium flux with IC50s < 10 nM. Balixafortide TFA is also a potent hematopoietic stem and progenitor cell (HSPC) mobilizing agent. Anti-cancer effects.
Molecular Weight:
1978.16
Purity:
99.0%
CAS Number:
[]
Formula:
C86H119F3N24O23S2
Target:
CXCR
* VAT and and shipping costs not included. Errors and price changes excepted
